Distinct biological roles for the akt family in mammary tumor progression
about
Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cellsDownregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4The critical role of Akt in cardiovascular functionThe pursuit of oncotargets through understanding defective cell regulationFilamin A phosphorylation by Akt promotes cell migration in response to arsenic2,2'-diphenyl-3,3'-diindolylmethane: a potent compound induces apoptosis in breast cancer cells by inhibiting EGFR pathwayrpS6 regulates blood-testis barrier dynamics through Akt-mediated effects on MMP-9SH3P2 is a negative regulator of cell motility whose function is inhibited by ribosomal S6 kinase-mediated phosphorylation.The determinants of head and neck cancer: Unmasking the PI3K pathway mutationsThe Huntington disease protein accelerates breast tumour development and metastasis through ErbB2/HER2 signalling.Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer.Cytoplasmic localization of p21 protects trophoblast giant cells from DNA damage induced apoptosis.CCR6 is a prognostic marker for overall survival in patients with colorectal cancer, and its overexpression enhances metastasis in vivo.JNK3 involvement in nerve cell apoptosis and neurofunctional recovery after traumatic brain injuryPTEN-deficient tumors depend on AKT2 for maintenance and survival.Akt1 is essential for postnatal mammary gland development, function, and the expression of Btn1a1.Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice.Differential apoptosis gene expressions of rhabdomyosarcoma cells in response to enterovirus 71 infection.Role of Notch and its oncogenic signaling crosstalk in breast cancer.The differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway.Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines.Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancerN-cadherin regulates mammary tumor cell migration through Akt3 suppression.Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathwayUnraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approachTargeting the phosphatidylinositol 3-kinase signaling pathway in breast cancer.Elevated PI3K signaling drives multiple breast cancer subtypes.Antiproliferative factor signaling and interstitial cystitis/painful bladder syndromePro-nerve growth factor induces autocrine stimulation of breast cancer cell invasion through tropomyosin-related kinase A (TrkA) and sortilin protein.miR-150 Deficiency Protects against FAS-Induced Acute Liver Injury in Mice through Regulation of AKTAkt2 inhibits the activation of NFAT in lymphocytes by modulating calcium release from intracellular storesPleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis.Role of phosphatidylinositol-3-kinase pathway in head and neck squamous cell carcinoma.A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development.Reprogramming during epithelial to mesenchymal transition under the control of TGFβPGE2 promotes renal carcinoma cell invasion through activated RalA.Dichotomy effects of Akt signaling in breast cancer.Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells.AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation.
P2860
Q26861403-94D28830-6D01-4458-9474-04F0E21477D9Q27332400-3E2E2500-4A68-44B6-AD1A-CB3B2EDE6B0CQ28083829-E130A4AD-E201-48F9-973C-27E538F24C92Q28395166-02E92604-841C-4EDD-8E25-3697C2899141Q28397930-312A5858-D2AC-424B-8F09-1EE75D178325Q28489107-A391F15D-5A4C-4EA2-B35B-13666B26B14FQ28575120-8227E95C-1E25-446B-818B-A9833EE4F338Q30155580-726A68CA-1219-484B-8C1A-13AC9B9EB4BEQ30365726-30EF772B-7045-4735-A0BE-D14CFDFDC7A6Q30535295-B42A248C-B0FF-444C-A15A-D3E13A5FFDACQ33564536-4504206C-B601-440C-B23B-B48B89BA4FE8Q33644593-2B3890F3-155E-490E-B6B4-86105CB3EC6DQ33825513-1EF03436-CBA4-42AF-9A74-3DECA710000DQ33937827-A95B0EC3-A6C4-432D-B354-6AE9A4813512Q34016861-735D0226-6913-4D05-A87A-77A61A61C685Q34019033-3E8F286A-E070-4A82-B0DD-C75F2B599411Q34181861-5AAFDA9A-D96D-4062-8A3D-7873152E4573Q34494794-621B6859-81EE-433F-A918-FE331526C5FEQ34697373-0465BA8B-BFDC-42C3-B66C-C1AD6123C986Q34746718-5CC11600-9D95-47D9-B42D-1D9DF6386966Q34836999-51303640-2C4D-4D2A-AA1C-BC4057849F7FQ35151491-0A86933D-B944-4BD7-9BBF-95BDC693D5F5Q35153665-89BE21DC-F350-4516-88A9-40BDA673633DQ35212521-377D229E-6BF3-4B6F-98C2-BAEC6C259D2AQ35310168-06BA37E1-1D69-4944-9B66-9EB3545D1CC8Q35312645-E77BB904-A2BF-441A-8E7D-E8D3A4A621B2Q35584560-E4E70679-9FF4-4587-88F7-6641DE95B897Q35640263-37E4D312-99DC-4903-8E08-6ED896D751EAQ35667287-8FEE2E18-1D5F-4C6E-8624-0EF7A99A7CADQ35694000-87774E33-FEF4-4C6D-A4B7-9D9CC9D69AB9Q35702495-136B04C4-2D2E-4643-B773-142F9FCBC122Q35786081-8717D8E4-377F-41B8-9EA0-7E03CFAC8334Q35935664-7E363EA8-BD47-482F-94DC-3AE8CB1A5C3AQ35994228-3BBD444B-47D5-4A9C-9BEA-F67E4EE75646Q36029588-1DEBA72B-AE5F-4635-AF24-DE1DE6A1CC39Q36124946-AFE56B79-EA51-42AE-85D4-CF8AAF1A2906Q36170200-A8F27899-1B3A-4385-97F0-B0CAF795FD9BQ36388391-F6FC8C48-ACB4-4BA9-80B7-F02B9C8E470FQ36652248-78EF8E82-C956-4046-AD3A-39AA71EA6F08Q36693202-E7D8D16B-0603-44BB-BC19-8D27F58583A3
P2860
Distinct biological roles for the akt family in mammary tumor progression
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Distinct biological roles for the akt family in mammary tumor progression
@en
Distinct biological roles for the akt family in mammary tumor progression.
@nl
type
label
Distinct biological roles for the akt family in mammary tumor progression
@en
Distinct biological roles for the akt family in mammary tumor progression.
@nl
prefLabel
Distinct biological roles for the akt family in mammary tumor progression
@en
Distinct biological roles for the akt family in mammary tumor progression.
@nl
P2860
P1433
P1476
Distinct biological roles for the akt family in mammary tumor progression
@en
P2093
Rachelle L Dillon
William J Muller
P2860
P304
P356
10.1158/0008-5472.CAN-10-0266
P407
P577
2010-04-27T00:00:00Z